Scientists may have just discovered that one of the world’s most talked-about medications has a remarkable hidden benefit. A major new study published in The Lancet Psychiatry has found that GLP-1 medications like semaglutide — the active ingredient in Ozempic, Wegovy, and Rybelsus — are associated with dramatic reductions in
